|
Volumn 172, Issue 11, 2005, Pages 1425-1426
|
Guidelines for STEMI [2] (multiple letters)
a b b b c d e f |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANADA;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
LETTER;
PERCUTANEOUS CORONARY INTERVENTION;
PRACTICE GUIDELINE;
SAFETY;
ST SEGMENT ELEVATION;
INTENSIVE CARE;
NOTE;
PATIENT REFERRAL;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
RESCUE PERSONNEL;
STANDARD;
TIME;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HEART MUSCLE REPERFUSION;
PATIENT PARTICIPATION;
RANDOMIZED CONTROLLED TRIAL;
SAMPLE SIZE;
ANGIOPLASTY, BALLOON;
CRITICAL CARE;
EMERGENCY MEDICAL TECHNICIANS;
HUMANS;
MYOCARDIAL INFARCTION;
REFERRAL AND CONSULTATION;
TIME FACTORS;
MYOCARDIAL REPERFUSION;
PATIENT PARTICIPATION;
PRACTICE GUIDELINES;
RANDOMIZED CONTROLLED TRIALS;
SAMPLE SIZE;
THROMBOLYTIC THERAPY;
|
EID: 20444427258
PISSN: 08203946
EISSN: None
Source Type: Journal
DOI: 10.1503/cmaj.1041728 Document Type: Letter |
Times cited : (2)
|
References (0)
|